NF1 and neoplasm: Altogether, we propose that the enhanced function of some NF1+/− immune cells in the tumor microenvironment of NF1 patients may favor the benign tumor state (i.e. NF1+/− mast cells, macrophages), but can also impair malignant transformation (i.e. NF1+/− T cells).